Nutri Pharma ASA – Trademark Portfolio

Entity Type: 03

Nutri Pharma ASA holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 29 (Meats & Processed Foods) across 4 Nice Classification classes. The owner is based in N-0160 Oslo.

Kronprinsesse Marthas Plass 1

N-0160 Oslo , NO

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NUTRI5
NUTRI5
Abandoned 2009
NUTRI5
NUTRI5
Cancelled 2008
ABACOR
ABACOR
Cancelled 1999
ABACOR
ABACOR
Cancelled 1998

Trademark Classifications

Nutri Pharma ASA's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

29
Meats & Processed Foods (2 filings)

Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits

32
Light Beverages (1 filing)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Nutri Pharma ASA have?

Nutri Pharma ASA has 6 U.S. trademarks filed with the USPTO.

What trademark classes does Nutri Pharma ASA file in?

Nutri Pharma ASA files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 32 (Light Beverages), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Nutri Pharma ASA's trademark registration success rate?

Nutri Pharma ASA has a 0% trademark registration rate, with 0 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.